Oxcan logo
Startup

Oxcan

See Oxcan's full profile

BOOK A DEMO
Headquarters

United Kingdom

Founded Year

2020

Total Funding

$1.7M

Employees

11 - 50

Status

Active


About Oxcan

Oxford Cancer Analytics Ltd is on a mission to realize curative cancer treatments through early detection. OXcan's machine learning platform enables minimally invasive and inexpensive cancer screening in high risk populations through analysing cancer materials shed into the blood.

Headquarters

United Kingdom


General Information on Oxcan

Brand name Oxcan
Company name Oxford Cancer Analytics Ltd.
Website https://www.oxcan.co.uk/
Founded year 2020
Employees 11 - 50
Founding team

Peter Jianrui Liu

Andreas Halner

Contact [email protected]

Find startup solutions in your specific business context

The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
BOOK A DEMO

Recent News and Activity about Oxcan

Sustainweb 01.04.2022
Sustain welcomes new member OXCAN

Sustain's Council of Trustees have approved the Sustainable Food and Farming Working Group from the Oxford Climate Alumni Network ( OXCAN ) to join the Sustain alliance. Connecting with Oxford University alumni working on climate change, OXCAN is building a library of the most useful climate change information, links and latest research from Oxford, whilst their working groups are a chance for those with expertise or interest in a particular ...

Oxcan news
Business Leader - UK 06.09.2021
OXcan secures £1.28m in oversubscribed seed funding round | News

OXcan (Oxford Cancer Analytics), a startup that uses machine learning and liquid biopsy for early lung cancer detection, recently raised £1.28M in an oversubscribed seed round and is now supported by Cancer Research UK, Civilisation Ventures, the Francis Crick Institute, Oxford Technology Management, and MegaRobo. Joining the international group of backers are business angels such as the Chief Digital Officer of T-Mobile USA, Marcus East, and ...

Oxcan news
Business Leader 06.09.2021
OXcan secures £1.28m in oversubscribed seed funding round

cancer detection, recently raised £1.28M in an oversubscribed seed round and is now supported by Cancer Research UK, Civilisation Ventures, the Francis Crick Institute, Oxford Technology Management, and MegaRobo.Joining the international group of backers are business angels such as the Chief Digital Officer of T-Mobile USA, Marcus East, and the former European President of GlaxoSmithKline, Brad Wilson.Every day in the UK, around 130 people are ...

Oxcan news